Nanoviricides (NNVC) Common Equity (2011 - 2026)
Nanoviricides' Common Equity came in at $8.68 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 15.5% from $7.52 million a year earlier but down 5.1% from the prior quarter.
Powered by 
Analysis
Nanoviricides (NNVC) Common Equity (2011 - 2026) Analysis & Trends
Going back to fiscal Q4 2011, Nanoviricides' Common Equity data covers 61 quarters.
- Common Equity carries a five-year compound annual growth rate of -21.9% (FY2021 to FY2026).
- Going back by fiscal year, Common Equity was $7.52 million in FY2025 (-34.4%), $11.46 million in FY2024 (-22.9%), $14.87 million in FY2023 (-35.6%) and $23.08 million in FY2022 (-22.8%).
- The five-year range for quarterly Common Equity is $7.17 million (fiscal Q1 2026) to $28.31 million (fiscal Q1 2022).
- Year-over-year, Common Equity has increased for three consecutive quarters, with an average decline of 11.7% over the last eight quarters.
- The fastest year-over-year change in Common Equity over five years came in fiscal Q4 2026 (growth of 15.5%), and the weakest in fiscal Q3 2024 (a decline of 41.6%).
- Business Quant data shows NNVC's Common Equity at $9.15 million (Q3 2026), $11.07 million (Q2 2026) and $7.17 million (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Nanoviricides | 30.18 Mn | 17.84 Mn | - | 8.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.68 Mn |
| Mar 31, 2026 | 9.15 Mn |
| Dec 31, 2025 | 11.07 Mn |
| Sep 30, 2025 | 7.17 Mn |
| Jun 30, 2025 | 7.52 Mn |
| Mar 31, 2025 | 8.83 Mn |
| Dec 31, 2024 | 10.39 Mn |
| Sep 30, 2024 | 10.11 Mn |
| Jun 30, 2024 | 11.46 Mn |
| Mar 31, 2024 | 10.65 Mn |
| Dec 31, 2023 | 12.45 Mn |
| Sep 30, 2023 | 12.97 Mn |
| Jun 30, 2023 | 14.87 Mn |
| Mar 31, 2023 | 18.23 Mn |
| Dec 31, 2022 | 19.87 Mn |
| Sep 30, 2022 | 21.56 Mn |
| Jun 30, 2022 | 23.08 Mn |
| Mar 31, 2022 | 24.76 Mn |
| Dec 31, 2021 | 26.47 Mn |
| Sep 30, 2021 | 28.31 Mn |
API Access
Nanoviricides Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=NNVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "NNVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=NNVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();